Published in Gene Therapy Weekly, April 10th, 2003
"We examined effects of recombinant p53-expressing adenovirus combined with thermoradiotherapy in eight head and neck squamous cell carcinoma (SCC) cell lines to improve the outcomes of the treatment of advanced head and neck cancer," stated Y. Higuchi and colleagues, Okayama University, Graduate School of Medicine and Dentristry.
"The p53 gene therapy did not improve the discrepancy between thermoradiosensitivities among the eight SCC cell lines. However, p53 gene therapy improved the effects of thermoradiotherapy in all eight cell lines, and there were significant...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly